We spoke to Dr Mustafa Zaman (Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh) at C3 2019 about his presentation at this year’s congress and his hopes for the future.
Speaker’s Disclosures: Mustafa Zaman has nothing to declare in relation to this video interview.
1. Please can you tell us about what you are presenting at this year’s C3 congress, and what you hope to achieve? (0:04)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
Share this Video
Related Videos In Interventional Cardiology
Erwan Donal, ESC 2022: The TriClip bRIGHT study for symptomatic patients with severe tricuspid regurgitation
The bRIGHT study aimed to evaluate the safety and effectiveness of the TriClip device in symptomatic patients with severe tricuspid regurgitation. In this touchCARDIO interview, we speak with Professor Erwan Donal (University Hospital of Rennes, Rennes, France) to discuss tricuspid transcatherter edge-to-edge repair, the difficulty in patient selection and the purpose and conclusions of the […]
PART ONE: Duk-Woo Park, ACC 2022: The efficacy and safety findings of the ADAPT-TAVR trial
touchCARDIO spoke to Dr Duk-Woo Park (Asan Medical Center, Seoul, South Korea) to discuss his presentation at the American College of Cardiology Annual Meeting 2022, providing the results of the ADAPT-TAVR trial of edoxaban versus dual antiplatelet therapy for valve thrombosis and cerebral thromboembolism after transcatheter aortic-valve replacement. (To view Part Two click here) Questions […]
PART TWO: Bon-Kwon Koo, ACC 2022: The FLAVOUR Trial: Comparison of FFR-guided and IVUS-guided PCI in intermediate coronary artery stenosis
touchCARDIO spoke to Prof Bon-Kwon Koo (Seoul National University College of Medicine, Seoul, South Korea) to discuss his presentation at the American College of Cardiology Annual Meeting 2022, providing the results of the FLAVOUR randomized clinical trial comparing fractional flow reserve-guided and intravascular ultrasound-guided percutaneous coronary intervention in intermediate coronary artery stenosis. Questions […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!